Patents by Inventor Xiaoxiao SONG

Xiaoxiao SONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibody specifically binding human and monkey CD38 antigens, preparation method and use thereof
    Patent number: 11976129
    Abstract: A monoclonal antibody specifically binding to human and monkey CD38 antigens or a derivative thereof includes: antigen complementarity-determining regions CDR1, CDR2 and CDR3 of an antibody light chain variable region having amino acid sequences as set forth in SEQ ID NO: 3, SEQ ID NO: 4 and SEQ ID NO: 5, respectively; and antigen complementarity-determining regions CDR1, CDR2 and CDR3 of an antibody heavy chain variable region having amino acid sequences as set forth in SEQ ID NO: 8, SEQ ID NO: 9 and SEQ ID NO: 10, respectively. The monoclonal antibody or derivative thereof can be used as a component of a pharmaceutical composition or prepared into a suitable pharmaceutical preparation, administered alone or combined with other therapeutic means such as chemotherapy drugs, for treating tumors with positive CD38 expression, such as human myeloma and human lymphoma.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: May 7, 2024
    Assignee: ACROIMMUNE BIOTECH CO., LTD.
    Inventors: Hongqun Hu, Xiaoqi Song, Zui Chen, Xiaoxiao Ma, Yanping Yuan, Qunmin Zhou
  • SYSTEM FOR PREDICTING THERAPY RESISTANCE AND ITS MOLECULAR MECHANISMS IN RECTAL CANCER BEFORE TREATMENT
    Publication number: 20240062915
    Abstract: A system for predicting therapy resistance and its molecular mechanisms in rectal cancer before treatment is provided. The system includes a feature extraction device, a collection device, a signature construction device and a prediction device. The system can predict responses to neoadjuvant therapy in patients before treatment, analyze patients who are resistant to rectal cancer therapy and their underlying molecular mechanism, thereby enabling personalized therapy for patients who are resistant to rectal cancer therapy. The system has important clinical significance in improving the overall survival of rectal cancer patients.
    Type: Application
    Filed: October 31, 2023
    Publication date: February 22, 2024
    Applicant: CANCER HOSPITAL, CHINESE ACADEMY OF MEDICAL SCIENCES
    Inventors: Qing ZHAO, Xu GUAN, Enrui LIU, Ran WEI, Xiaoxiao SONG
  • Functionalized single-layer graphene-based thin film composite and method of producing the same
    Patent number: 10918998
    Abstract: A functionalized single-layer graphene-based thin film composite and method of producing the same are disclosed. Furthermore, a functionalized single-layer graphene-based thin film composite having water channels for low pressure desalination and method of producing the same are disclosed.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: February 16, 2021
    Assignee: NGEE ANN POLYTECHNIC
    Inventors: James Antony Prince, Sowrirajalu Bhuvana, Xiaoxiao Song, Gurdev Singh
  • FUNCTIONALIZED SINGLE-LAYER GRAPHENE-BASED THIN FILM COMPOSITE AND METHOD OF PRODUCING THE SAME
    Publication number: 20180147545
    Abstract: A functionalized single-layer graphene-based thin film composite and method of producing the same are disclosed. Furthermore, a functionalized single-layer graphene-based thin film composite having water channels for low pressure desalination and method of producing the same are disclosed.
    Type: Application
    Filed: April 20, 2016
    Publication date: May 31, 2018
    Inventors: James Antony PRINCE, Sowrirajalu BHUVANA, Xiaoxiao SONG, Gurdev SINGH